The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human phase 1a trial of sintilimab (IBI308), a monoclonal antibody targeting programmed death-1 (PD-1), in Chinese patients with advanced solid tumors.
 
Jian-Ming Xu
No Relationships to Disclose
 
Ru Jia
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose
 
Rongrui Liu
No Relationships to Disclose
 
Chuanhua Zhao
No Relationships to Disclose
 
Hui Zhou
No Relationships to Disclose
 
Linxinyu Xu
No Relationships to Disclose
 
Xuan Kong
No Relationships to Disclose